SASeda Banu Akıncı

Seda Banu Akıncı

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seda Banu Akıncı has a total of 243 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Purple urine bag syndrome

    by Yakup Güdek, Oğuzhan Külahlı, Nuriye Sidar Arslan, Nergis Öztürk, Adnan Menderes Vural, Seda Banu Akıncı

    Purple Urine Bag Syndrome (PUBS) is an uncommon clinical condition that is generally benign but rarely encountered by clinicians. It occurs due to the metabolism of tryptophan by intestinal bacteria, followed by hepatic conjugation. In the urine, bacterial sulfatase and phosphatase enzymes lead to the production of indigo and indirubin pigments, whose oxidation results in the characteristic purple discoloration. We report the case of a 61-year-old female patient with known chronic obstructive pulmonary disease (COPD) and psoriasis. Due to inadequate oral enteral nutrition, a nutritional supplement was prescribed. Approximately seven hours after administration, purple discoloration of the urine bag was observed. Urine culture revealed growth of Proteus mirabilis, and the urine pH was 8.5. As the colony count was low, antibiotic therapy was not initiated. After discontinuation of the nutritional product, the urine color returned to normal. Although PUBS is typically benign, catastrophic outcomes have been reported in delayed cases. Therefore, increasing awareness among healthcare professionals and ensuring early recognition and management are of vital importance.

  • Open Access

    Comparison of pre-mixed multichamber bags versus compounded parenteral nutrition

    by Seda Banu Akıncı, Zeynep Şahiner, Canan Esin Sağlam, Melahat Yalçın Solak, Y. Nilgün Ölmez, Meltem Gülhan Halil

    Objective: Parenteral nutrition (PN) is commonly used in patients with prolonged catabolic states when enteral feeding is not feasible. PN can be administered via pre-mixed multichamber bags (MCBs) or compounded bags (COBs). This study compares the biochemical, clinical effects, and complications of MCB and COB nutrition. Methods: We retrospectively reviewed adult patients who received TPN in 2020 in an University Hospital. Patients were grouped based on receiving MCB or COB. Demographic data, lab values, hospital stay, and complications (hyperglycemia, refeeding syndrome, CRBSIs) were analyzed. Results: A total of 235 patients were included. Hyperglycemia was more common in the MCB group, while CRBSI occurred more frequently in the COB group. COB patients more frequently met protein goals. Other biochemical and clinical outcomes were similar between groups. Conclusion: MCB and COB both have unique advantages and drawbacks. Critically ill patients should be monitored closely regardless of PN formulation.


  • Open Access

    Teamwork effectiveness in intensive care units: development and validation of a brief and reliable assessment tool (TES-ICU)

    by Murat Tümer, Zeynep Aycan, Banu Kılıçaslan, Elif Selva Oruç, Seda Banu Akıncı

    Effective teamwork is essential for patient safety and quality of care in intensive care units (ICUs), where complexity, high cognitive demands, and multidisciplinary collaboration prevail. Despite its critical role, there is a lack of validated instruments specifically designed to assess teamwork effectiveness in ICUs. This study aimed to develop and validate a context-specific tool—the Teamwork Effectiveness Scale in Intensive Care Units (TES-ICU). The study was conducted in two phases. In Study 1, a comprehensive item pool was generated through literature review and expert evaluation. Items were tested for clarity and distributional properties, and an exploratory factor analysis (EFA) was used to refine the pool. In Study 2, the psychometric properties of the resulting 30-item TES-ICU were evaluated using a nationwide sample of ICU professionals in Türkiye (N = 716). Validity was assessed by examining associations with job satisfaction, organizational commitment, burnout, and turnover intention. Reliability was evaluated using Cronbach’s alpha. EFA revealed a three-factor structure explaining 56.76% of the variance: (1) Teamwork Effectiveness (16 items), (2) Effective Communication and Error Management (11 items), and (3) Effective Leadership (3 items). All subscales demonstrated high internal consistency (α > 0.85). The TES-ICU showed strong construct validity; it was positively associated with job satisfaction and commitment and negatively associated with burnout and turnover intention. The TES-ICU is a reliable and valid tool to assess teamwork effectiveness in ICU settings. It can guide interventions aimed at improving team dynamics, enhancing staff well-being, and ultimately contributing to better patient outcomes. The 16-item core scale may be used as a shorter form for research or quality improvement efforts.


  • Open Access

    Postoperative Analgesia After Hand Surgery: A Controlled Comparison of Dexketoprofen Trometamol and Paracetamol

    by Funda Arun, Fatma Sarıcaoğlu, Banu Kılıçaslan, Seda Banu Akıncı, Gürsel Leblebicioğlu, Ülkü Aypar

    Aim: This prospective, randomized, double-blind study compared the efficacy and safety of dexketoprofen trometamol (DT) and paracetamol in managing postoperative pain for patients undergoing intravenous regional anesthesia (IVRA) during hand surgery. Methods: Sixty-six ASA I-II patients aged 18-70 were enrolled after exclusion criteria, including drug allergies, psychiatric disorders, Raynaud’s disease, and anticoagulant therapy. Patients were randomized into two groups: Group 1 received 25 mg DT, and Group 2 received 500 mg paracetamol for postoperative pain relief. At home postoperatively, pain intensity was assessed using the visual analog scale (VAS), and rescue analgesia was provided if needed. Patients recorded pain relief efficacy, satisfaction levels, side effects, and tablet consumption over 30 hours. Results: While both DT and paracetamol provided adequate postoperative pain relief, key differences were observed. Group 1 reported significantly higher analgesic efficacy (p = 0.001) and satisfaction levels (p = 0.003), with 75.8% of patients experiencing complete pain relief compared to 42.4% in Group 2. Moreover, postoperative morphine requirements were significantly lower in Group 1 (p = 0.04), highlighting its superior ability to manage pain while minimizing opioid use. VAS scores at various postoperative intervals showed no statistically significant differences between the two groups. However, Group 1 reached peak pain intensity at 6 hours postoperatively, while Group 2 peaked at 12 hours, suggesting DT's faster onset of action. Both groups demonstrated similar demographic and surgical characteristics, ensuring robust comparability. The frequency of side effects, such as nausea, vomiting, headache, and insomnia, was low and comparable between the groups (p > 0.05), underscoring the safety profiles of both drugs. Conclusions: DT offers superior postoperative pain control, reduced opioid reliance, and higher patient satisfaction compared to paracetamol following IVRA in ambulatory hand surgery. These findings support DT as a promising alternative to paracetamol in multimodal analgesia strategies. Additional studies are needed to confirm these findings and examine the mechanisms behind the differences in observed outcomes. The choice of analgesic should remain patient-specific, considering individual clinical conditions, contraindications, and preferences.

  • Open Access

    COVID-19 hastalarında toraks tomografi görüntülemelerinde iskelet-kas indeks ölçümlerinin hasta sonuçlarını belirleyebilmekteki öngörüsü

    by Seda Banu Akıncı, Erhan Akpınar, Cemile Altın, Nihal Deniz Bulut Yüksel, Najmaddin Abdurrahimli

    Giriş ve Amaç: Sarkopeni, uzamış mekanik ventilasyon (MV) ve yoğun bakım ünitesine (YBÜ) kalış süresine neden olmakta ve COVID-19 hastalarında sık görülmektedir. Torasik tomografi görüntülemesinden hesaplanan kesitsel kas alanı ölçümü, sarkopeni varlığını değerlendirmek için kullanılan bir yöntemlerden biridir. Çalışmamızda, COVID-19 pnömonisi hastalarına, YBÜ yatışında çekilen akciğer BT görüntülemelerinden elde edilen kas ve yağ dokusu hacim ölçümlerinin MV, YBÜ ve hastane kalış süreleri ve mortalite oranları açısından prognostik değerini araştırmayı amaçladık. Yöntem ve Gereçler: Etik kurul onayı alındıktan sonra Ağustos 2020-Şubat 2021 tarihleri arasında Hacettepe Hastanesi Anestezi Yoğun Bakım Ünitesine COVID PCR pozitif ve solunum sıkıntısı nedeni ile yatışı yapılan erişkin hastalar retrospektif olarak tarandı. Yoğun bakıma yatış öncesi akciğer BT görüntüsü olmayan veya görüntü kalitesi yeterli olmayan hastalar çalışma dışı bırakıldı. Hastaların demografik verileri, laboratuvar parametreleri, başvuru APACHEII, SOFA, NUTRIC skorları, mekanik ventilasyon, yoğun bakım ve hastanede kalış süreleri, 28 ve 90 gündeki mortalite oranları hastane bilgi sisteminden kaydedildi. İstatistiksel analizler için Ki-Kare Testleri, Mann-Whitney U testleri, Spearman korelasyonları, çok değişkenli ikili lojistik regresyon testleri kullanıldı. Bulgular: Toplam 139 hasta çalışmaya dahil edildi. Ortalama MV süresi 7 gün, YBÜ kalış süresi 17 gün ve 90 günlük mortalite oranı %43 idi. Hesaplan kas ve yağ doku hacmi ölçümü ile NUTRIC skor, MV, YBÜ ve hastane kalış süreleri arasında istatistiksel olarak anlamlı bir ilişki tespit edilemedi. NUTRIC skor ile MV (p <0.01, r = 0.364) ve YBÜ (p = 0.011, r =0.216) kalış süreleri ve 14. gün prealbumin değeri (p<0.01, r= 0.496) arasında istatistiksel olarak anlamlı korelasyon bulundu. Yatış günü hesaplanan NUTRIC (B=0.558, p.026) ve SOFA (B=0.760, p.001) skorları mortalitenin bağımsız belirleyicileri olarak tespit edildi. Tartışma ve Sonuç: Toraks BT görüntülerinden elde edilen kas ve yağ doku hacmi ölçümlerinin MV ve YBÜ kalış sürelerini ve mortaliteyi tahmin etmede prognostik değeri yoktur, bununla birlikte NUTRIC skor COVID-19 pnömonisi ile YBÜ’de takip edilen kritik hastalarda mortaliteyi öngören bir belirteçtir.

  • A Look at Thyroid Functions as a Predictor on Prognosis of Critically Ill Patients in İntensive Care Units from the Perspective of Covid-19.

    by Murat Tümer, Nihal Deniz Bulut Yüksel, Banu Kılıçarslan, Seda Banu Akıncı

    Aim: Thyroid gland can be affected both by cytokine storm and through angiotensin-converting enzyme-2 receptors. A worse prognosis has been described in patients with low fT3 levels. The aim of this study is to evaluate the prognostic significance of thyroid function during COVID-ICU hospitalization. Methods: After ethical approval, 100 COVID-19 patients followed in the ICU between March 2020 and April 2021 was admitted to study. Patients with previous thyroid disease were excluded from study. Free triiodothyronine (fT3), free thyroxine (fT4), and thyroid-stimulating hormone (TSH) levels at ICU admission were evaluated. Clinical, demographic, laboratory, treatment, and outcome data were obtained from the patient's electronic hospital records. Mann Whitney U, Spearman correlation, binary logistic, and linear regression tests were used for statistical analysis. Results: TSH was in 31 patients, fT3 was in 37 patients, and fT4 was in 54 patients, which were outside the normal ranges. fT3 were lower in non-survivors than the survivors (p: 0.036). However, the fT3 level was not the independent factor for mortality rate in linear regression analysis (p=0,652). APACHE II and procalcitonin levels as independent predictors of mortality (p: 0,017). fT3 remained an independent factor for the length of ICU stay (p=0,024) and the length of hospital stay (p=0,031). Conclusion: fT3 is a prognostic indicator that can predict hospital and ICU length of stay in critically ill patients with Covid-19. In the future, a broader panel of validated biochemical markers, including fT3 levels, may become a simple tool for stratified management of patients with severe COVID-19.

  • Open Access

    The Impact of CoronaVac Vaccination on 28-day Mortality Rate of Critically Ill Patients with COVID-19 in Türkiye

    by Fethi Gül, Umut Sabri Kasapoğlu, Mehmet Süleyman Sabaz, Pınar Ay, Burçin Doruk Oktay, Gülbahar Çalışkan, Nalan Demir, İsmet Sayan, Feyyaz Kabadayı, Gülsüm Altuntaş, et al.

    Background: Vaccines against coronavirus disease-19 (COVID-19) have been effective in preventing symptomatic diseases, hospitalizations, and intensive care unit (ICU) admissions. However, data regarding the effectiveness of COVID-19 vaccines in reducing mortality among critically ill patients with COVID-19 remains unclear.Aims: To determine the vaccination status and investigate the impact of the COVID-19 vaccine on the 28-day mortality in critically ill patients with COVID-19.Study Design: Multicenter prospective observational clinical study.Methods: This study was conducted in 60 hospitals with ICUs managing critically ill patients with COVID-19. Patients aged >= 18 years with confirmed COVID-19 who were admitted to the ICU were included. The present study had two phases. The first phase was designed as a one-day point prevalence study, and demographic and clinical findings were evaluated. In the second phase, the 28-day mortality was evaluated.Results: As of August 11, 2021, 921 patients were enrolled in the study. The mean age of the patients was 65.42 +/- 16.74 years, and 48.6% (n = 448) were female. Among the critically ill patients with COVID-19, 52.6% (n = 484) were unvaccinated, 7.7% (n = 71) were incompletely vaccinated, and 39.8% (n = 366) were fully vaccinated. A subgroup analysis of 817 patients who were unvaccinated (n = 484) or who had received two doses of the CoronaVac vaccine (n = 333) was performed. The 28-day mortality rate was 56.8% (n = 275) and 57.4% (n = 191) in the unvaccinated and two-dose CoronaVac groups, respectively. The 28-day mortality was associated with age, hypertension, the number of comorbidities, type of respiratory support, and APACHE II and sequential organ failure assessment scores (p < 0.05). The odds ratio for the 28-day mortality among those who had received two doses of CoronaVac was 0.591 (95% confidence interval: 0.413-0.848) (p = 0.004).Conclusion: Vaccination with at least two doses of CoronaVac within six months significantly decreased mortality in vaccinated patients than in unvaccinated patients.


  • Open Access

    Yoğun Bakım

    by Işıl Özkoçak Turan, Derya Gökçınar, Gökşen Bağçecik Öz, Melek Doğancı, Seval İzdeş, Umut Kara, Ahmet Coşar, Nevzat Mehmet Mutlu, Melike Korkmaz Toker, Yavuz Demiraran, et al.

    Bu basım, kritik bakım doktorları ve eğitimdeki yoğun bakım yan dal asistanlarına ek olarak tüm kritik bakım sağlayıcıları- hospitalistlerine, alt branş doktorlara, asistanlara, hemşirelere, doktor asistanlarına, hemşire pratisyenlere, beslenmecilere, eczacılara, solunum terapistlerine ve tıp öğrencilerine değerli bir kaynak olması için tasarlanmıştır.

  • Open Access

    Do antimicrobial stewardship programs improve the quality of care in ICU patients diagnosed with infectious diseases following consultation? Experience in a tertiary care hospital

    by Gamze Gursoy, Omrum Uzun, Gokhan Metan, Mehmet Yildirim, Melda Bahap, Salih Kutay Demirkan, Arzu Topeli, Seda Banu Akinci, Mehmet Akif Topcuoglu, Mustafa Berker, et al.


  • Remote Ischemic Conditioning Increases Organ Injury in Murine Sepsis: Experimental Research

    by Seda Banu Akinci, Fatma Saricaoglu, Melih Akinci, Huseyin Cihad Turgut, Naciye Dilara Zeybek, Sevda Muftuoglu